BamSEC and AlphaSense Join Forces
Learn More

Spero Therapeutics Inc. – Articles of Incorporation

NASDAQ: SPRO    
Share price (8/17/26): $1.19    
Market cap (8/17/26): $69.3 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 1 page Certificate of Amendment to Restated Certificate of Incorporation of Spero Therapeutics, Inc
12/34/56
EX-3.1
from 10-Q 23 pages Amended and Restated Bylaws of Spero Therapeutics, Inc
12/34/56
EX-3.1
from 8-K/A 2 pages Certificate of Correction of Amended and Restated Certificate of Incorporation, as Amended of Spero Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to Amended and Restated Certificate of Incorporation, as Amended of Spero Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to Restated Certificate of Incorporation of Spero Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 18 pages Spero Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 17 pages Spero Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 12 pages Spero Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 13 pages Spero Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.3
from S-1/A 13 pages Spero Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.2
from 8-K 20 pages Amended and Restated Bylaws of Spero Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 10 pages Amended and Restated Certificate of Incorporation of Spero Therapeutics, Inc
12/34/56
EX-3.5
from S-1/A 20 pages Amended and Restated Bylaws of Spero Therapeutics, Inc
12/34/56
EX-3.3
from S-1/A 10 pages Restated Certificate of Incorporation of Spero Therapeutics, Inc
12/34/56
EX-3.2
from S-1/A 4 pages State of Delaware Secretary of State Division of Corporations Delivered 08:16 Am 10/20/2017 Filed 08:16 Am 10/20/2017 Sr 20176708286 - File Number 5448287 Certificate of Amendment to Restated Certificate of Incorporation of Spero Therapeutics, Inc
12/34/56
EX-3.4
from S-1 16 pages Spero Therapeutics, Inc. By-Laws
12/34/56
EX-3.1
from S-1 39 pages Amended and Restated Certificate of Incorporation of Spero Therapeutics, Inc. Amended and Restated Certificate of Incorporation of Spero Therapeutics, Inc
12/34/56
EX-3
from DRS 16 pages Spero Therapeutics, Inc. By-Laws
12/34/56
EX-3
from DRS 39 pages Amended and Restated Certificate of Incorporation of Spero Therapeutics, Inc. Amended and Restated Certificate of Incorporation of Spero Therapeutics, Inc
12/34/56